Related Experiment Video
Updated: Feb 18, 2026

Author Spotlight: Utilizing Next-Generation Polymerized Human Hemoglobin for Improved Donor Lung Evaluation and Preservation in Rats
Published on: June 14, 2024
Patients as a Limited Resource? Ethical Dilemmas in Pediatric Pulmonary Vein Stenosis
Insights
For rare pediatric diseases like pulmonary vein stenosis (PVS), patient care decisions must balance current treatment needs with the limited research resources future patients rely on. Regionalizing care is ethically supported.
Area of Science:
- Pediatric Surgery
- Medical Ethics
- Rare Diseases
Background:
- Pediatric pulmonary vein stenosis (PVS) is a rare, severe cardiopulmonary disease.
- PVS treatment has evolved rapidly, often outpacing robust clinical evidence.
- Patients with rare diseases represent a limited resource for research crucial for future treatments.
Purpose of the Study:
- To explore the ethical tensions between rarity, research needs, and clinical decision-making in surgical diseases.
- To examine the ethical implications of using patients as a resource for research in rare diseases.
- To evaluate proposals for managing rare diseases, specifically PVS.
Main Methods:
- Case study analysis of pediatric pulmonary vein stenosis (PVS).
- Examination of the history of PVS treatment and clinical changes.
- Ethical interrogation of resource utilization, research priorities, and patient welfare.
Main Results:
- Regionalizing PVS treatment is ethically justifiable.
- Standardizing care across all centers for PVS is not ethically justifiable.
- Current patients are stakeholders in clinical management decisions due to their role as a research resource.
Conclusions:
- Clinical management of rare diseases should consider research and resource implications.
- Patient welfare and the standard of care must be preserved when incorporating research considerations.
- Balancing the dual role of patients as care recipients and research resources is ethically possible under specific conditions.
Abstract:
AbstractThis study explores tensions between rarity, research, and clinical decision-making in surgical diseases through a case study of pediatric pulmonary vein stenosis (PVS), an extremely rare and severe pediatric cardiopulmonary disease. We first examine the history of PVS treatment and illustrate how the field has been characterized by rapid clinical changes that outpace evidence. Through this context, we characterize patients and their ability to contribute to research as a limited resource that future patients depend on. We argue that this establishes future patients as legitimate stakeholders in decisions regarding current-day clinical management. Exploring this tension, we ask, to what extent should just resource utilization and research priorities shape clinical decisions, and can the dual role of patients-both as care recipients and as a limited resource-be ethically balanced? The article interrogates these questions through two proposals: standardizing care across centers, and regionalizing PVS treatment. We argue that regionalization is ethically justifiable, whereas standardization is not. Ultimately, we conclude that while a patient's primary role is as a recipient of care, research and resource considerations can and should still inform clinical management of rare diseases. Importantly, this is ethically possible only under conditions that preserve patient welfare and the accepted standard of care.
More Related Videos
Related Concept Videos
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Ethical Issues
Ethical Concerns in Healthcare:
Ethical Dilemmas II
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Ethics and Bioethics
Pharmacokinetics in Pediatric Patients: Drug Excretion

